A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:2247-56.

Slides:

Advertisements

Similar presentations

A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.

Advertisements

The golden hour(s) for severe sepsis and septic shock treatment

A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.

Presenters for Journal Club: James Cooper Eugenie Shieh Aaron Schueneman Tim Niessen.

1 Hetastarch Administration in Patients Undergoing Open Heart Surgery in Association with Cardiopulmonary Bypass (CPB) Blood Products Advisory Committee.

Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intravenous Maintenance Fluids Friedman JN, Beck CE, DeGroot J, Geary DF, Sklansky.

Colloid versus Crystalloid in Hypovolemic Shock Controversy

Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.

Maitland K et al ,N Engl J Med 2011;364:

Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.

Clash of the titans: Colloids versus crystalloids Eric A J Hoste Intensive Care Unit Ghent University Hospital Belgium.

1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.

In a patient who has sustained blunt trauma who is found to have an occult pneumothorax on CT scan, is tube thoracostomy better than observation at reducing.

Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients A Randomized Trial Journal Club 09/01/11 JAMA, February 4, 2009—Vol 301, No

Enhanced recovery meta-analysis Kirsty Cattle Research Registrar.

Management of Neutropenic Sepsis Rebecca Frewin Consultant Haematologist Gloucestershire Hospitals NHS Foundation Trust.

The SAFE Study (Saline v Albumin Fluid Evaluation) Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood.

Sugar control in Critical care unit Senior clinical pharmacist : Lihua Fang Koo Foundation Cancer Center.

Sarah Struthers, MD March 19, 2015

Mr PS 76 years old COPD, no DM Severe CAP Day 1- intubated, sedated, high o2 requirements, vasopressor dependent Starting early EN Glucose 11.1 mmol/L.

Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院劉慧萍藥師.

Iatrogenic Anemia in the ICU Anh Nguyen, MD, MPH, PGY2.

Clinical Trial Designs An Overview. Identify: condition(s) of interest, intended population, planned treatment protocols Recruitment of volunteers: volunteers.

Nicolai Haase, MD, PhD Department of Intensive Care Copenhagen University Hospital - Rigshospitalet Resuscitating sepsis – how I do it after 6S 4th International.

Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds)

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Albumin Safety and Efficacy as a Resuscitative Therapy in the ICU: Are all ICU patients the same? Gary R. Haynes, M.D., Ph.D. Professor, Department of.

Monthly Journal article review: Vimmi Kang PGY 2

EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.

TEMPLATE DESIGN © Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.

Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.

Fluids & AKI Fluids are GOOD Volume overload is BAD UGLY Fluids cause AKI.

BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced.

Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology

ITU Journal Club: Dr. Clinton Jones. ST4 Anaesthetics.

Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.

Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.

Haemofiltration for sepsis: burial or resurrection?

Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.

Evidence and Medicine. Bradford Hill Strength of association Consistency of association SpecificityTemporality Biologic gradient PlausibilityCoherenceExperimentationAnalogy.

Copenhagen University Hospital Rigshospitalet, Denmark

Choice of fluid in sepsis University of Copenhagen Anders Perner Dept of Intensive Care, Rigshospitalet, University of Copenhagen Scandinavian Critical.

Safety of Albumin Revisited Blood Products Advisory Committee Meeting March 17, 2005 Laurence Landow MD, FRCPC.

Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.

Baseline Characteristics of the Patients* - Part I The ONTARGET Investigators. N Engl J Med 2008 [Epub on Mar 31]

STICH CABG Objective To determine whether surgery plus medical management or medical management alone improve outcomes in CABG patients Study Design 1212.

Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.

Steroid Therapy.

Retrospective Monocentric 10-Year Analysis Of Sepsis-Associated Acute Kidney Injury: Impact On Outcome, Dialysis Dose And Residual Renal Function 1 Vincenzo.

Towards Global Eminence K Y U N G H E E U N I V E R S I T Y j 내과 R2 이지영.

Effect of Pressure Support vs Unassisted Breathing Through a Tracheostomy Collar on Weaning Duration in Patients Requiring Prolonged Mechanical Ventilation.

LSU Journal Club Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia A Systematic Review and Meta-analysis Scott Hebert,

Anything else? Glucose – tight control must be better NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill.

Statins The AURORA Trial Reference Fellstrom BC. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360. A.

Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.

Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck

Introduction Methods Results Conclusion

Copenhagen University Hospital Rigshospitalet, Denmark

Advanced Ventilation Research

Early Goal Directed Therapy Fondazione Ospedale Maggiore

Advances in Vasodilatory Shock:

PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma.

CIBIS II: Cardiac Insufficiency Bisoprolol Study II

BACKGROUND The optimal timing of RRT initiation in critically ill patients with AKI is still uncertain No consensus to guide clinical practice of acute.

Monthly Journal article review: Vimmi Kang PGY 2

PPI prophylaxis for GI bleeding in ICU

The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care CLASSIC Trial Tine Sylvest Meyhoff,

The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care CLASSIC Trial Tine Sylvest Meyhoff,

Presentation transcript:

A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:2247-56.

Background Conflicting results from meta-analyses comparing saline to albumin on survival of critically ill patients exist. Cochrane Injuries Group Albumin Reviewers’ meta-analysis of 24 studies and 1419 patients suggested albumin increased the absolute risk of death by 6 percent compared to crystalloid. No adequately powered randomized, controlled trials have examined the effects of fluid choice on the survival of patients in the ICU. NEJM 2004 350;22:2247-56.

Hypothesis When 4% albumin is compared to 0.9% sodium chloride for intravascular resuscitation in the ICU there will be no difference in 28 day rate of death from any cause. NEJM 2004 350;22:2247-56.

Methods 16 ICUs in Australia and New Zealand 6997 patients 3497 received albumin, 3500 received saline Randomized, blinded Inclusion criteria Fluid replacement needed and 4% albumin or 0.9% sodium chloride acceptable At least one clinical sign of hypovolemia Exclusion criteria A/E human albumin, religion, plasmapheresis, cardiac surgery, burns, liver transplantation, < 18 years, brain death, moribund, previous enrollment, previous fluid resuscitation. NEJM 2004 350;22:2247-56.

Outcome Measures Primary outcome measures Secondary outcome measures 28 day all cause mortality Secondary outcome measures 28 day survival time Number of new organ failures Duration of mechanical ventilation Duration of renal replacement therapy Duration of ICU and hospital LOS Subgroup comparison Trauma, sepsis, ARDS NEJM 2004 350;22:2247-56.

Results- Primary and Secondary Outcomes Outcome Albumin(3473) Saline(3460) RR (95% CI) P value Status at 28 days: No.(%) Death 726(20.9) 729(21.1) 0.99 (0.91 to 1.09) 0.87 Alive in ICU 111(3.2) 87(2.5) 1.27 (0.96 to 1.68) 0.09 Alive in HOS 793(22.8) 848(24.5) 0.93 (0.86 to 1.01) 0.10 Outcome Albumin(3473) Saline(3460) AD (95% CI) P value ICU LOS (d) 6.56.6 6.26.2 0.24 (-0.06 to 0.54) 0.44 HOS LOS (d) 15.39.6 15.69.6 -0.24 (-0.70 to 0.21) 0.30 Vent days 4.56.1 4.3±5.7 0.19 (-0.08 to 0.47) 0.74 RRT days 0.482.28 0.392.0 0.09 (-0.0 to 0.19) 0.41 No difference in 0-5 new organ failures (p=0.85) NEJM 2004 350;22:2247-56.

Results- New Organ Failures New organ failure-no. (%) p=0.85* No (%) Albumin Saline 1 organ 1397 (52.7) 1424 (53.3) 2 organs 795 (30.0) 796(29.8) 3 organs 369 (13.9) 361 (13.5) 4 organs 68 (2.6) 75 (2.8) 5 organs 2 (0.1) 0 *The P value pertains to the comparison between the albumin and saline groups In the numbers of patients who had no new organ failure of new failure of one, Two, three, four, or five organs. NEJM 2004 350;22:2247-56.

Probability of Survival Results NEJM 2004 350;22:2247-56.

Results- Mortality by Subgroup Death within 28 days by subgroup: No./total (%) Albumin Saline RR (95% CI) P value Trauma 81/596 (13.6) 59/590 (10.0) 1.36 (0.99 to 1.86) 0.06 Severe Sepsis 185/603 (30.7) 217/615 (35.3) 0.87 (0.74 to 1.02) 0.09 ARDS 24/61 (39.3) 28/66 (42.4) 0.93 (0.61 to 1.41) 0.72 Study had insufficient power to detect small differences in mortality among subgroups. NEJM 2004 350;22:2247-56.

Relative Risk of Death NEJM 2004 350;22:2247-56.

Summary 4 percent albumin or normal saline for intravascular volume resuscitation in a heterogeneous population resulted in equivalent rates of death at 28 days. Mechanical ventilation, ICU and hospital days and renal replacement therapy needs were equivalent. Findings do not support Cochrane Injuries Group Albumin Reviewers meta-analysis. NEJM 2004 350;22:2247-56.

Conclusion “ Our study provides evidence that albumin and saline should be considered clinically equivalent treatments for intravascular volume resuscitation in a heterogeneous population of patients in the ICU. Whether albumin or saline confers benefit in highly select populations of critically ill patients requires further study.” NEJM 2004 350;22:2247-56.